{"recordsFiltered":48535,"recordsTotal":48535,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=31200","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=30600","results":[{"registry_id":"NCT06597214","publication_url":"https://clinicaltrials.gov/study/NCT06597214","title":"Intraoperative Warming: Comparison of Performance of the AVAcore Technologies warmUP™ Temperature Management System (WU-20) and the Arizant Bair Hugger Temperature Management System","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Tampa General Hospital","sponsor_slug":"tampa-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05505565","publication_url":"https://clinicaltrials.gov/study/NCT05505565","title":"Continuous Glucose Monitors in the Management of Youth With Prediabetes","has_exemption":false,"start_date":"2023-06-05","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04716231","publication_url":"https://clinicaltrials.gov/study/NCT04716231","title":"A Phase 2b/3, Multi-part, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With IgA Nephropathy (IgAN)","has_exemption":false,"start_date":"2023-06-29","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Vera Therapeutics, Inc.","sponsor_slug":"vera-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06121063","publication_url":"https://clinicaltrials.gov/study/NCT06121063","title":"The Efficacy and Safety of a CCT-102 Regimen or Expectant Management in the Treatment of First Trimester Pregnancy Loss","has_exemption":false,"start_date":"2023-07-21","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Conceptra Biosciences, LLC","sponsor_slug":"conceptra-biosciences-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05992896","publication_url":"https://clinicaltrials.gov/study/NCT05992896","title":"Can Loco-regional Anesthesia With Liposomal Bupivacaine Reduce Intra- and Post-operative Narcotic Use in Patients Undergoing Lower Extremity Revascularization? A Prospective, Triple Blinded, Randomized Trial.","has_exemption":false,"start_date":"2023-09-26","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06236516","publication_url":"https://clinicaltrials.gov/study/NCT06236516","title":"One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors (ONE STOP)","has_exemption":false,"start_date":"2024-02-26","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06713330","publication_url":"https://clinicaltrials.gov/study/NCT06713330","title":"A 36-Month Prospective Randomized Clinical Pilot Trial Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth","has_exemption":false,"start_date":"2024-05-17","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06441162","publication_url":"https://clinicaltrials.gov/study/NCT06441162","title":"A Pilot, Non-randomized, Single-site Clinical Study Investigating the Efficacy of Combined Therapy of Nebulized 3% Hypertonic Saline and Chest Percussion Therapy in Pediatric Patients With Acute Viral Bronchiolitis.","has_exemption":false,"start_date":"2024-07-15","completion_date":"2025-05-15","has_results":true,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06578949","publication_url":"https://clinicaltrials.gov/study/NCT06578949","title":"A Phase 3, Single-arm, Open-label, Multicenter Study to Assess the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Complement Inhibitor Treatment Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China","has_exemption":false,"start_date":"2024-10-10","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06716749","publication_url":"https://clinicaltrials.gov/study/NCT06716749","title":"Effectiveness of Adding Morphine to Intraosseous Vancomycin for Pain Control in Total Knee Arthroplasty: A Double-Blind, Randomized Trial","has_exemption":false,"start_date":"2024-12-01","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06712251","publication_url":"https://clinicaltrials.gov/study/NCT06712251","title":"Early Feasibility Study of the Velocity™ Percutaneous Arterio-Venous Fistula System","has_exemption":false,"start_date":"2025-01-08","completion_date":"2025-05-15","has_results":false,"results_due":false,"sponsor_name":"Venova Medical","sponsor_slug":"venova-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03025308","publication_url":"https://clinicaltrials.gov/study/NCT03025308","title":"A Multicenter, Open-label, Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects With Rheumatoid Arthritis","has_exemption":false,"start_date":"2017-02-28","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"Alfasigma S.p.A.","sponsor_slug":"alfasigma-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716739","publication_url":"https://clinicaltrials.gov/study/NCT03716739","title":"Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency","has_exemption":false,"start_date":"2019-03-19","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05119296","publication_url":"https://clinicaltrials.gov/study/NCT05119296","title":"Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer","has_exemption":false,"start_date":"2022-02-15","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04966507","publication_url":"https://clinicaltrials.gov/study/NCT04966507","title":"A Randomized Crossover Study to Evaluate the Efficacy of Antibacterial Mouthwash in Preventing Pharyngeal Gonorrhea Among a High Risk Population","has_exemption":false,"start_date":"2022-02-17","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05536414","publication_url":"https://clinicaltrials.gov/study/NCT05536414","title":"A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects With Major Depressive Disorder","has_exemption":false,"start_date":"2022-09-12","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327556","publication_url":"https://clinicaltrials.gov/study/NCT05327556","title":"Epinephrine in the Pediatric Intensive Care Unit: A Dose-Effect Trial (EPI Dose)","has_exemption":false,"start_date":"2023-02-08","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05798923","publication_url":"https://clinicaltrials.gov/study/NCT05798923","title":"A Phase 2a Single-Arm, Open-Label, Exploratory Study to Assess the Effects of LAM-001 for the Treatment of Pulmonary Hypertension","has_exemption":false,"start_date":"2023-04-03","completion_date":"2025-05-16","has_results":false,"results_due":false,"sponsor_name":"OrphAI Therapeutics","sponsor_slug":"orphai-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05488509","publication_url":"https://clinicaltrials.gov/study/NCT05488509","title":"Acute Effects of Cannabis on Everyday Life Memory","has_exemption":false,"start_date":"2023-08-21","completion_date":"2025-05-17","has_results":false,"results_due":false,"sponsor_name":"Washington State University","sponsor_slug":"washington-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06042257","publication_url":"https://clinicaltrials.gov/study/NCT06042257","title":"Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)","has_exemption":true,"start_date":"2024-12-09","completion_date":"2025-05-17","has_results":false,"results_due":false,"sponsor_name":"Rachel G. Greenberg, MD, MB, MHS","sponsor_slug":"rachel-g-greenberg-md-mb-mhs","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04086745","publication_url":"https://clinicaltrials.gov/study/NCT04086745","title":"A Randomized, Controlled Pragmatic Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis","has_exemption":false,"start_date":"2020-02-14","completion_date":"2025-05-19","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05243680","publication_url":"https://clinicaltrials.gov/study/NCT05243680","title":"A Multi-centre, Single Arm, Open-label Extension Study to Evaluate the Long-term Safety of GSK3511294 (Depemokimab) in Adult and Adolescent Participants With Severe Asthma With an Eosinophilic Phenotype From Studies 206713 or 213744","has_exemption":false,"start_date":"2022-03-01","completion_date":"2025-05-19","has_results":true,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05128383","publication_url":"https://clinicaltrials.gov/study/NCT05128383","title":"An Open-label Proof of Concept Study Regarding the Efficacy and Safety of Dupilumab in the Treatment of Keloids","has_exemption":false,"start_date":"2023-01-13","completion_date":"2025-05-19","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05734690","publication_url":"https://clinicaltrials.gov/study/NCT05734690","title":"COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure","has_exemption":false,"start_date":"2023-05-05","completion_date":"2025-05-19","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05837234","publication_url":"https://clinicaltrials.gov/study/NCT05837234","title":"A Prospective, Open-Label, Multi-Center Trial to Evaluate the Safety and Effectiveness of Ultra Low Frequency Spinal Cord Stimulation in Patients With Chronic Low Back Pain","has_exemption":false,"start_date":"2023-05-09","completion_date":"2025-05-19","has_results":false,"results_due":false,"sponsor_name":"Presidio Medical, Inc","sponsor_slug":"presidio-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557499","publication_url":"https://clinicaltrials.gov/study/NCT06557499","title":"A Randomized, Data Analyst-masked, 3-way Cross-over, Pivotal Clinical Investigation to Evaluate the Performance of Two Polyurethane Male Condoms With Different Size and Thickness in Healthy Monogamous Couples During Vaginal Intercourse Compared With a Commercially Available Thin Latex Male Condom.","has_exemption":false,"start_date":"2024-08-23","completion_date":"2025-05-19","has_results":false,"results_due":false,"sponsor_name":"Reckitt Benckiser Healthcare (UK) Limited","sponsor_slug":"reckitt-benckiser-healthcare-uk-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02005289","publication_url":"https://clinicaltrials.gov/study/NCT02005289","title":"A Phase II Study of MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)/Prolymphocytic Leukemia (PLL), Including Those Who Have Relapsed on Ibrutinib, or Patients With Untreated CLL/SLL/PLL and an Open Pilot Study for Patients With Richters Transformation (RT)","has_exemption":false,"start_date":"2014-01-17","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04052880","publication_url":"https://clinicaltrials.gov/study/NCT04052880","title":"A Phase 2 Study of Subcutaneous Daratumumab in Combination With Dose-Attenuated Bortezomib, Lenalidomide, and Dexamethasone in Elderly Newly Diagnosed Multiple Myeloma Patients","has_exemption":false,"start_date":"2019-10-24","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Larysa Sanchez","sponsor_slug":"larysa-sanchez","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05018416","publication_url":"https://clinicaltrials.gov/study/NCT05018416","title":"A Phase 2, Randomized, Open-Labeled, Repeat Dose, Safety and Efficacy Study of Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN-007)","has_exemption":true,"start_date":"2021-07-27","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Prokidney","sponsor_slug":"prokidney","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133075","publication_url":"https://clinicaltrials.gov/study/NCT06133075","title":"Using Mirabegron to Increase Blood Pressure in Patients With Postural Orthostatic Tachycardia Syndrome","has_exemption":false,"start_date":"2023-12-22","completion_date":"2025-05-20","has_results":true,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06152042","publication_url":"https://clinicaltrials.gov/study/NCT06152042","title":"Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants With Type 1 Diabetes Mellitus","has_exemption":false,"start_date":"2023-12-28","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Biomea Fusion Inc.","sponsor_slug":"biomea-fusion-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619340","publication_url":"https://clinicaltrials.gov/study/NCT06619340","title":"A Case Series Assessing the Clinical Utility of EXPAREL As an Intra-articular Posteromedial Surgeon Administered (IPSA) Block in Patients Undergoing Primary Unilateral Total Knee Arthroplasty","has_exemption":false,"start_date":"2024-05-20","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Campbell Clinic","sponsor_slug":"campbell-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06410924","publication_url":"https://clinicaltrials.gov/study/NCT06410924","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Treatment With DD01 for 48 Weeks in Overweight/Obese Subjects With MASLD/MASH","has_exemption":false,"start_date":"2024-06-13","completion_date":"2025-05-20","has_results":false,"results_due":false,"sponsor_name":"Neuraly, Inc.","sponsor_slug":"neuraly-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06533527","publication_url":"https://clinicaltrials.gov/study/NCT06533527","title":"Randomized Trial of Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy","has_exemption":false,"start_date":"2024-07-31","completion_date":"2025-05-20","has_results":true,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03290950","publication_url":"https://clinicaltrials.gov/study/NCT03290950","title":"Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly-Diagnosed Multiple Myeloma: A Clinical and Correlative Phase II Study","has_exemption":false,"start_date":"2017-09-25","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04895722","publication_url":"https://clinicaltrials.gov/study/NCT04895722","title":"A Phase 2, Multicenter, Multi Arm, Study to Evaluate MK-1308A (Co-formulated Quavonlimab (MK-1308)/Pembrolizumab) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer: (MK-1308A-008)","has_exemption":false,"start_date":"2021-06-25","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05172596","publication_url":"https://clinicaltrials.gov/study/NCT05172596","title":"A Phase 2 Study of PHE885, B-cell Maturation Antigen (BCMA)- Directed CAR-T Cells in Adult Participants With Relapsed and Refractory Multiple Myeloma.","has_exemption":false,"start_date":"2022-03-03","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05267262","publication_url":"https://clinicaltrials.gov/study/NCT05267262","title":"A Phase II, Multi-center, Open-Label Study to Assess Safety, Tolerability, Efficacy and Pharmacokinetics of R3R01 in AS Patients With Uncontrolled Proteinuria on ACE/ARB Inhibition and in Patients With Primary Steroid-Resistant FSGC","has_exemption":false,"start_date":"2022-06-15","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"River 3 Renal Corp.","sponsor_slug":"river-3-renal-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05735015","publication_url":"https://clinicaltrials.gov/study/NCT05735015","title":"Phase 2 Study of the PTH-Independent Effects of Encaleret on Mineral Homeostasis in Subjects With Post-Surgical Hypoparathyroidism (PSH)","has_exemption":false,"start_date":"2023-09-01","completion_date":"2025-05-21","has_results":true,"results_due":false,"sponsor_name":"National Institute of Dental and Craniofacial Research (NIDCR)","sponsor_slug":"national-institute-of-dental-and-craniofacial-research-nidcr","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06034743","publication_url":"https://clinicaltrials.gov/study/NCT06034743","title":"A Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension","has_exemption":false,"start_date":"2023-11-22","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06238817","publication_url":"https://clinicaltrials.gov/study/NCT06238817","title":"A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis","has_exemption":false,"start_date":"2024-04-26","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594185","publication_url":"https://clinicaltrials.gov/study/NCT06594185","title":"A Prospective, Multicenter, Open Label, Single Arm, Post-Marketing Clinical Study to Evaluate Real World Outcomes of the enVista® Aspire (EA) and Aspire Toric (ETA) Intraocular Lens in Subjects Undergoing Cataract Extraction","has_exemption":false,"start_date":"2024-08-29","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Bausch & Lomb Incorporated","sponsor_slug":"bausch-lomb-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06528457","publication_url":"https://clinicaltrials.gov/study/NCT06528457","title":"A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Examine the Prophylactic and Treatment Effects of a Single Dose Level of Oral Fenretinide in a Dengue Virus Challenge Model","has_exemption":false,"start_date":"2024-09-05","completion_date":"2025-05-21","has_results":false,"results_due":false,"sponsor_name":"Island Pharmaceuticals","sponsor_slug":"island-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02520154","publication_url":"https://clinicaltrials.gov/study/NCT02520154","title":"Matched Paired Pharmacodynamics and Feasibility Study of Pembrolizumab in Combination With Chemotherapy in Frontline Ovarian Cancer","has_exemption":false,"start_date":"2016-07-05","completion_date":"2025-05-22","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03659617","publication_url":"https://clinicaltrials.gov/study/NCT03659617","title":"Clinical, Radiographic and Histomorphotmetric Analysis of Healing Dynamics in Human Extraction Sockets Grafted With Bio-Oss Collagen®: A Prospective 3-year Post-loading Study","has_exemption":false,"start_date":"2018-12-10","completion_date":"2025-05-22","has_results":true,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04412096","publication_url":"https://clinicaltrials.gov/study/NCT04412096","title":"Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance","has_exemption":false,"start_date":"2020-11-23","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04649229","publication_url":"https://clinicaltrials.gov/study/NCT04649229","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3","has_exemption":false,"start_date":"2021-05-27","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04827745","publication_url":"https://clinicaltrials.gov/study/NCT04827745","title":"A Multicenter Phase II Study of Blinatumomab for Treatment of Adult Patients With Morphologic Relapsed/Refractory or Measurable Residual Disease (MRD) CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)","has_exemption":false,"start_date":"2021-06-11","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05186753","publication_url":"https://clinicaltrials.gov/study/NCT05186753","title":"A Multi-Part, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of The Safety and Efficacy of CGT9486 in Subjects With Nonadvanced Systemic Mastocytosis","has_exemption":false,"start_date":"2022-06-27","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Cogent Biosciences, Inc.","sponsor_slug":"cogent-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05516498","publication_url":"https://clinicaltrials.gov/study/NCT05516498","title":"A Two Part Phase IIa/b Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Dose-ranging Study to Assess Efficacy, Safety, and Tolerability of the Combination of Zibotentan and Dapagliflozin, and Dapagliflozin Monotherapy Versus Placebo in Participants With Cirrhosis With Features of Portal Hypertension","has_exemption":false,"start_date":"2022-10-31","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05630859","publication_url":"https://clinicaltrials.gov/study/NCT05630859","title":"A Phase 1/2, Observer-blind, Randomized, Placebo-controlled Multi-country Study to Assess Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age","has_exemption":false,"start_date":"2022-11-28","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757856","publication_url":"https://clinicaltrials.gov/study/NCT05757856","title":"An Open-label Phase 2 Study Assessing the Safety, Tolerability and Preliminary Diagnostic Performance of a Radioactive Imaging Agent, NDX-3315 and NDX-3324, in Healthy Adult Participants and Patients With Eosinophilic Esophagitis","has_exemption":true,"start_date":"2023-01-20","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"NexEos Diagnostics, Inc.","sponsor_slug":"nexeos-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05795699","publication_url":"https://clinicaltrials.gov/study/NCT05795699","title":"A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Subjects With Fuchs Endothelial Corneal Dystrophy","has_exemption":false,"start_date":"2023-03-30","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Kowa Research Institute, Inc.","sponsor_slug":"kowa-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06024590","publication_url":"https://clinicaltrials.gov/study/NCT06024590","title":"Outcomes of Chlorhexidine Gluconate Irrigation as an Adjunctive Treatment in the Management of Diabetic Foot Ulcers","has_exemption":false,"start_date":"2023-10-03","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Northern Illinois Foot and Ankle Specialists","sponsor_slug":"northern-illinois-foot-and-ankle-specialists","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05996523","publication_url":"https://clinicaltrials.gov/study/NCT05996523","title":"Phase II Trial of Immunotherapeutic HPV Vaccine PRGN-2009 With Pembrolizumab Before Standard Treatment in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal Cancer","has_exemption":false,"start_date":"2023-11-07","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06429059","publication_url":"https://clinicaltrials.gov/study/NCT06429059","title":"ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments","has_exemption":false,"start_date":"2024-06-12","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06342310","publication_url":"https://clinicaltrials.gov/study/NCT06342310","title":"A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)","has_exemption":false,"start_date":"2024-06-14","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"Reunion Neuroscience Inc","sponsor_slug":"reunion-neuroscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05521880","publication_url":"https://clinicaltrials.gov/study/NCT05521880","title":"Anchoring Intermittent Long Acting Antimicrobials to Medication for Opioid Use Disorder Treatment to Facilitate Structured Transitions of Care for People Who Use Drugs Admitted to the Hospital With Invasive Infections","has_exemption":false,"start_date":"2024-07-15","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597747","publication_url":"https://clinicaltrials.gov/study/NCT06597747","title":"Evaluating Design Improvements With SONNET 3 in Experienced Cochlear Implant Users","has_exemption":false,"start_date":"2024-12-16","completion_date":"2025-05-22","has_results":true,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06845540","publication_url":"https://clinicaltrials.gov/study/NCT06845540","title":"Oral Metformin in the Treatment of Melasma: a Prospective Trial in Latin American Women","has_exemption":false,"start_date":"2025-02-20","completion_date":"2025-05-22","has_results":false,"results_due":false,"sponsor_name":"University of Puerto Rico","sponsor_slug":"university-of-puerto-rico","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02530489","publication_url":"https://clinicaltrials.gov/study/NCT02530489","title":"Triple-Negative First-Line Study: Neoadjuvant Trial of Nab-Paclitaxel and MPDL3280A, a PDL-1 Inhibitor in Patients With Triple Negative Breast Cancer","has_exemption":false,"start_date":"2016-02-04","completion_date":"2025-05-23","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02955290","publication_url":"https://clinicaltrials.gov/study/NCT02955290","title":"A Phase I/II Basket Trial of the EGF Vaccine CIMAvax in Combination With Anti-PD1 Therapy in Patients With Advanced NSCLC or Squamous Head and Neck Cancer","has_exemption":false,"start_date":"2016-12-22","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03872479","publication_url":"https://clinicaltrials.gov/study/NCT03872479","title":"Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Efficacy of EDIT-101 in Adult and Pediatric Participants With Leber Congenital Amaurosis Type 10 (LCA10), With Centrosomal Protein 290 (CEP290)-Related Retinal Degeneration Caused by a Compound Heterozygous or Homozygous Mutation Involving c.2991+1655A>G in Intron 26 (IVS26) of the CEP290 Gene (\"LCA10-IVS26\")","has_exemption":false,"start_date":"2019-09-26","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Editas Medicine, Inc.","sponsor_slug":"editas-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04337970","publication_url":"https://clinicaltrials.gov/study/NCT04337970","title":"A Phase Ib/II Study of Talazoparib and Axitinib in Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2020-04-06","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04263597","publication_url":"https://clinicaltrials.gov/study/NCT04263597","title":"Oral Supplementation of 2'-Fucosyllactose in Allogeneic Bone Marrow Transplant Recipients to Maintain Intestinal Homeostasis","has_exemption":false,"start_date":"2020-08-26","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05242471","publication_url":"https://clinicaltrials.gov/study/NCT05242471","title":"A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Induction and Maintenance Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease","has_exemption":false,"start_date":"2022-07-22","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05403866","publication_url":"https://clinicaltrials.gov/study/NCT05403866","title":"A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Multiple Doses of LT3001 Drug Product in Subjects With Acute Ischemic Stroke (AIS)","has_exemption":false,"start_date":"2022-08-17","completion_date":"2025-05-23","has_results":true,"results_due":false,"sponsor_name":"Lumosa Therapeutics Co., Ltd.","sponsor_slug":"lumosa-therapeutics-co-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07175727","publication_url":"https://clinicaltrials.gov/study/NCT07175727","title":"Safety and Efficacy of New, Non-thermal Ablation Techniques for the Treatment of Atrial Fibrillation - A Comparison of Two Ablation Systems","has_exemption":false,"start_date":"2023-01-24","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Alfried Krupp Krankenhaus","sponsor_slug":"alfried-krupp-krankenhaus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05609370","publication_url":"https://clinicaltrials.gov/study/NCT05609370","title":"A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer","has_exemption":false,"start_date":"2023-01-29","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"BeiGene","sponsor_slug":"beigene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04725383","publication_url":"https://clinicaltrials.gov/study/NCT04725383","title":"Amitriptyline for Repetitive Behaviors in Children and Adolescents With Autism Spectrum Disorders","has_exemption":false,"start_date":"2023-11-01","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"University of Missouri, Kansas City","sponsor_slug":"university-of-missouri-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06465108","publication_url":"https://clinicaltrials.gov/study/NCT06465108","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate the Safety, Pharmacokinetics, and Efficacy of MBX 2109 in Patients With Hypoparathyroidism (Avail Study)","has_exemption":true,"start_date":"2024-08-08","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"MBX Biosciences","sponsor_slug":"mbx-biosciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06386744","publication_url":"https://clinicaltrials.gov/study/NCT06386744","title":"Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease","has_exemption":false,"start_date":"2024-11-18","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"Soligenix","sponsor_slug":"soligenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06749912","publication_url":"https://clinicaltrials.gov/study/NCT06749912","title":"Effects of a Lower Back Wrap Device on Lower Back Pain, Physical Function, and Quality of Life","has_exemption":false,"start_date":"2024-12-02","completion_date":"2025-05-23","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03678753","publication_url":"https://clinicaltrials.gov/study/NCT03678753","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects With PGTC Seizures","has_exemption":false,"start_date":"2018-09-21","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"SK Life Science, Inc.","sponsor_slug":"sk-life-science-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04717414","publication_url":"https://clinicaltrials.gov/study/NCT04717414","title":"A Phase 3, Double-blind, Randomized Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK Inhibitor Therapy and Who Require Red Blood Cell Transfusions","has_exemption":false,"start_date":"2021-02-25","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04798339","publication_url":"https://clinicaltrials.gov/study/NCT04798339","title":"A Phase 1b/2 Study Evaluating the Safety and Efficacy of Canakinumab With Darbepoetin Alfa in Patients With Lower-Risk Myelodysplastic Syndromes (MDS) Who Have Failed Erythropoietin Stimulating Agents (ESA)","has_exemption":false,"start_date":"2021-03-30","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05376176","publication_url":"https://clinicaltrials.gov/study/NCT05376176","title":"A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study","has_exemption":false,"start_date":"2022-05-19","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"Santen Inc.","sponsor_slug":"santen-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05336786","publication_url":"https://clinicaltrials.gov/study/NCT05336786","title":"Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)","has_exemption":false,"start_date":"2022-06-15","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06310382","publication_url":"https://clinicaltrials.gov/study/NCT06310382","title":"A Phase I/II Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Antitumor Activity of GH55 in Patients Harboring MAPK Pathway Mutations in Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-07","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"Suzhou Genhouse Bio Co., Ltd.","sponsor_slug":"suzhou-genhouse-bio-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05683496","publication_url":"https://clinicaltrials.gov/study/NCT05683496","title":"A Phase 1/2, Adaptive, Multiple Dose Ranging Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of Lonigutamab in Subjects With Thyroid Eye Disease (TED)","has_exemption":false,"start_date":"2023-02-14","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"ACELYRIN Inc.","sponsor_slug":"acelyrin-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04717934","publication_url":"https://clinicaltrials.gov/study/NCT04717934","title":"Main Study: A Randomized, Evaluator-blinded, No-treatment Controlled, Multicenter Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Sub-study to Assess Interpretation of Mammograms Following Treatment for Correction of Wrinkles in the Décolletage Area in the Investigational Study 43USRV1906","has_exemption":true,"start_date":"2025-02-11","completion_date":"2025-05-26","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03963375","publication_url":"https://clinicaltrials.gov/study/NCT03963375","title":"Cladribine Tablets: Collaborative Study to Evaluate the Impact On Central Nervous System Biomarkers in Multiple Sclerosis","has_exemption":false,"start_date":"2019-10-28","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03993171","publication_url":"https://clinicaltrials.gov/study/NCT03993171","title":"A Phase 2, Open-Label, Sequential Group, Investigator Blinded Study of Magnetic Resonance Spectroscopy (31P-MRS) to Assess the Effects of CNM-Au8 for the Bioenergetic Improvement of Impaired Neuronal Redox State in Multiple Sclerosis.","has_exemption":false,"start_date":"2019-12-19","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Clene Nanomedicine","sponsor_slug":"clene-nanomedicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04513925","publication_url":"https://clinicaltrials.gov/study/NCT04513925","title":"A Phase III, Open-Label, Randomized Study of Atezolizumab and Tiragolumab Compared With Durvalumab in Patients With Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer Who Have Not Progressed After Concurrent Platinum-Based Chemoradiation","has_exemption":false,"start_date":"2020-08-24","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04321954","publication_url":"https://clinicaltrials.gov/study/NCT04321954","title":"A Phase 2 Study of Neoadjuvant Lenvatinib in Locally Advanced Invasive Thyroid Cancer","has_exemption":false,"start_date":"2021-03-09","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Massachusetts Eye and Ear Infirmary","sponsor_slug":"massachusetts-eye-and-ear-infirmary","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123053","publication_url":"https://clinicaltrials.gov/study/NCT05123053","title":"Amifampridine for the Treatment of Transient Vocal Weakness After OnabotulinumtoxinA Injection for Spasmodic Dysphonia","has_exemption":false,"start_date":"2021-10-28","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Augusta University","sponsor_slug":"augusta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04933695","publication_url":"https://clinicaltrials.gov/study/NCT04933695","title":"A Phase 2, Multicenter, Open-label Study of Sotorasib (AMG 510) in Subjects With Stage IV NSCLC Whose Tumors Harbor a KRAS G12C Mutation in Need of First-line Treatment (CodeBreaK 201)","has_exemption":false,"start_date":"2022-01-28","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04656470","publication_url":"https://clinicaltrials.gov/study/NCT04656470","title":"Neuroimaging Study of Dexmedetomidine-Induced Analgesia","has_exemption":false,"start_date":"2022-03-04","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05556096","publication_url":"https://clinicaltrials.gov/study/NCT05556096","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel, Multicenter Study to Evaluate the Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis","has_exemption":true,"start_date":"2022-11-21","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05961332","publication_url":"https://clinicaltrials.gov/study/NCT05961332","title":"COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy (COCO-GA) Protocol","has_exemption":false,"start_date":"2023-10-06","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06140407","publication_url":"https://clinicaltrials.gov/study/NCT06140407","title":"A Single Arm Trial of Adjuvant Pembrolizumab in Patients With Limited Stage Small Cell Lung Cancer","has_exemption":false,"start_date":"2024-02-14","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt-Ingram Cancer Center","sponsor_slug":"vanderbilt-ingram-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06269107","publication_url":"https://clinicaltrials.gov/study/NCT06269107","title":"A 40-week Study Comparing the Efficacy and Safety of Once Weekly IcoSema and Daily Insulin Glargine 100 Units/mL in Participants With Type 2 Diabetes Inadequately Controlled on Oral Anti Diabetic Drugs COMBINE 4","has_exemption":false,"start_date":"2024-02-15","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06381596","publication_url":"https://clinicaltrials.gov/study/NCT06381596","title":"Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration: New Insights From Multimodal Imaging","has_exemption":false,"start_date":"2024-04-16","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619847","publication_url":"https://clinicaltrials.gov/study/NCT06619847","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy","has_exemption":false,"start_date":"2024-10-29","completion_date":"2025-05-27","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03915964","publication_url":"https://clinicaltrials.gov/study/NCT03915964","title":"A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients With Rheumatoid Arthritis","has_exemption":false,"start_date":"2019-04-25","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04370093","publication_url":"https://clinicaltrials.gov/study/NCT04370093","title":"Pathogenesis of Uric Acid Nephrolithiasis: Role of Pioglitazone/Weight Loss","has_exemption":false,"start_date":"2019-10-17","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04426669","publication_url":"https://clinicaltrials.gov/study/NCT04426669","title":"A Phase I/II Trial in Patients With Metastatic Gastrointestinal Epithelial Cancer Administering Tumor-Infiltrating Lymphocytes in Which the Gene Encoding CISH Was Inactivated Using the CRISPR/Cas9 System","has_exemption":false,"start_date":"2020-05-15","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Intima Bioscience, Inc.","sponsor_slug":"intima-bioscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04849910","publication_url":"https://clinicaltrials.gov/study/NCT04849910","title":"A First-In-Human, Open-Label, Multicenter Study of VOR33 in Patients With Acute Myeloid Leukemia Who Are at High-Risk for Leukemia Relapse Following Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2021-12-16","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Vor Biopharma","sponsor_slug":"vor-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05037123","publication_url":"https://clinicaltrials.gov/study/NCT05037123","title":"Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain","has_exemption":false,"start_date":"2022-01-04","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04955743","publication_url":"https://clinicaltrials.gov/study/NCT04955743","title":"A Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 Experienced","has_exemption":false,"start_date":"2022-02-09","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05274243","publication_url":"https://clinicaltrials.gov/study/NCT05274243","title":"2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis","has_exemption":false,"start_date":"2022-08-09","completion_date":"2025-05-28","has_results":true,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05560646","publication_url":"https://clinicaltrials.gov/study/NCT05560646","title":"A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age With Moderate to Severe Endometriosis-related Pain","has_exemption":false,"start_date":"2022-10-25","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Organon and Co","sponsor_slug":"organon-and-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05418725","publication_url":"https://clinicaltrials.gov/study/NCT05418725","title":"Ground-Breaking Electroporation-based Intervention for PERSistent Atrial Fibrillation Treatment (BEAT PERS-AF)","has_exemption":false,"start_date":"2022-11-04","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Bordeaux","sponsor_slug":"university-hospital-bordeaux","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05624268","publication_url":"https://clinicaltrials.gov/study/NCT05624268","title":"A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression","has_exemption":false,"start_date":"2023-01-19","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565457","publication_url":"https://clinicaltrials.gov/study/NCT04565457","title":"A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality","has_exemption":false,"start_date":"2023-04-21","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05627596","publication_url":"https://clinicaltrials.gov/study/NCT05627596","title":"Effectiveness of Nicotine Replacement Therapy Sampling in Dental Practices","has_exemption":false,"start_date":"2023-06-12","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Hennepin Healthcare Research Institute.","sponsor_slug":"hennepin-healthcare-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06069544","publication_url":"https://clinicaltrials.gov/study/NCT06069544","title":"A Randomized, Dose-escalation Phase I/IIa Trial With Controlled Human Malaria Infection to Evaluate Safety, Tolerability, Immunogenicity and Efficacy of an Investigational RNA-based Vaccine for Prevention of P. Falciparum Malaria in Healthy Malaria naïve Adults","has_exemption":true,"start_date":"2023-11-13","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Biontech SE","sponsor_slug":"biontech-se","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05984199","publication_url":"https://clinicaltrials.gov/study/NCT05984199","title":"Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients With Relapsed or Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2023-12-11","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Vor Biopharma","sponsor_slug":"vor-biopharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369220","publication_url":"https://clinicaltrials.gov/study/NCT06369220","title":"A Study of the Clinical Utility of Point of Care Cobas® Liat CT/NG/MG Nucleic Acid Test Versus Current Standard Practice","has_exemption":false,"start_date":"2024-07-29","completion_date":"2025-05-28","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03598309","publication_url":"https://clinicaltrials.gov/study/NCT03598309","title":"Phase II Trial of Investigational Agents to Modulate Intermediate Endpoint Biomarkers, Including Pulmonary Nodules, in Former and Current Smokers","has_exemption":false,"start_date":"2019-06-05","completion_date":"2025-05-29","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04134845","publication_url":"https://clinicaltrials.gov/study/NCT04134845","title":"A Randomized Controlled Trial of RyR2 Inhibition With Dantrolene and Susceptibility to Ventricular Arrhythmias in Patients With Structural Heart Disease.","has_exemption":false,"start_date":"2020-08-21","completion_date":"2025-05-29","has_results":true,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05869669","publication_url":"https://clinicaltrials.gov/study/NCT05869669","title":"A Phase 2b Clinical Study of the P38 Alpha Kinase Inhibitor Neflamapimod in Patients With Dementia With Lewy Bodies","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-05-29","has_results":false,"results_due":false,"sponsor_name":"EIP Pharma Inc","sponsor_slug":"eip-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04240756","publication_url":"https://clinicaltrials.gov/study/NCT04240756","title":"2/2 Treating Mothers with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial","has_exemption":false,"start_date":"2020-08-06","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, College Park","sponsor_slug":"university-of-maryland-college-park","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04724668","publication_url":"https://clinicaltrials.gov/study/NCT04724668","title":"The Role of the Circadian System in Binge Eating Disorder","has_exemption":false,"start_date":"2021-01-15","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04764292","publication_url":"https://clinicaltrials.gov/study/NCT04764292","title":"Screening Contrast-Enhanced Mammography as an Alternative to MRI","has_exemption":false,"start_date":"2021-02-15","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Wendie Berg","sponsor_slug":"wendie-berg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04887480","publication_url":"https://clinicaltrials.gov/study/NCT04887480","title":"Direct Resuscitation of the Open Peritoneum: A Randomized Controlled Trial in Non-Traumatic Patients","has_exemption":false,"start_date":"2021-05-14","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Sanford Health","sponsor_slug":"sanford-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04738942","publication_url":"https://clinicaltrials.gov/study/NCT04738942","title":"An Open-Label, Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intravenous (IV) Vedolizumab Administered Every 4 Weeks (Q4W) in Japanese Patients With Moderate to Severe Ulcerative Colitis or Crohn's Disease Who Experienced Secondary Loss of Response During Maintenance Therapy With Vedolizumab IV Administered Every 8 Weeks (Q8W)","has_exemption":false,"start_date":"2021-06-04","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04746924","publication_url":"https://clinicaltrials.gov/study/NCT04746924","title":"A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab in Patients With Previously Untreated, PD-L1-Selected, and Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-06-08","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"BeiGene","sponsor_slug":"beigene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04879732","publication_url":"https://clinicaltrials.gov/study/NCT04879732","title":"Roentgen Stereophotogrammetric Analysis (RSA): ACTIS Hip Stem","has_exemption":false,"start_date":"2021-10-05","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Canadian Radiostereometric Analysis Network","sponsor_slug":"canadian-radiostereometric-analysis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06263985","publication_url":"https://clinicaltrials.gov/study/NCT06263985","title":"Prospective Analysis of Axis(TM) Solvent-dehydrate Dermal Allograft in the Treatment of Pelvic Organ Prolapse.","has_exemption":false,"start_date":"2021-11-02","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Michigan Institution of Women's Health PC","sponsor_slug":"michigan-institution-of-womens-health-pc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05059236","publication_url":"https://clinicaltrials.gov/study/NCT05059236","title":"Open-label Study of Androgen Receptor Inhibition With dArolutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Men With Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm","has_exemption":false,"start_date":"2021-11-04","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05219500","publication_url":"https://clinicaltrials.gov/study/NCT05219500","title":"PSMA-directed Targeted Alpha Therapy With FPI-2265 (225Ac-PSMA-I&T) for the Treatment of Metastatic Castration-resISTant Prostate Cancer (TATCIST). A Phase II Clinical Trial.","has_exemption":false,"start_date":"2021-12-16","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Fusion Pharmaceuticals Inc.","sponsor_slug":"fusion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04535999","publication_url":"https://clinicaltrials.gov/study/NCT04535999","title":"Phase IV Open Label Study of the Effects of Secukinumab on Nail Psoriasis and Non-Invasive Measures of Enthesitis","has_exemption":false,"start_date":"2022-02-07","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04849884","publication_url":"https://clinicaltrials.gov/study/NCT04849884","title":"A Prospective, Multi-Center, Post-Market Clinical Study to Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System in Total Knee Arthroplasty Procedures.","has_exemption":false,"start_date":"2022-02-10","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Smith & Nephew, Inc.","sponsor_slug":"smith-nephew-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05250973","publication_url":"https://clinicaltrials.gov/study/NCT05250973","title":"A Phase 2, Multicohort Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis","has_exemption":false,"start_date":"2022-03-01","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05155254","publication_url":"https://clinicaltrials.gov/study/NCT05155254","title":"An Open-label, Randomized, Phase 3 Clinical Trial of IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Patients With Previously Untreated, Unresectable, or Metastatic (Advanced) Melanoma (IO102-IO103-013 / MK3475-D18)","has_exemption":false,"start_date":"2022-05-17","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"IO Biotech","sponsor_slug":"io-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05272150","publication_url":"https://clinicaltrials.gov/study/NCT05272150","title":"A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Guselkumab for the Treatment of Participants With Skin of Color Who Have Moderate-to-Severe Plaque Psoriasis and/or Moderate-to-Severe Scalp Psoriasis","has_exemption":false,"start_date":"2022-07-13","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05537285","publication_url":"https://clinicaltrials.gov/study/NCT05537285","title":"Individualized Neuromodulation for Anhedonic Depression","has_exemption":false,"start_date":"2022-08-01","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05528263","publication_url":"https://clinicaltrials.gov/study/NCT05528263","title":"Preventing Chemotherapy-Induced Peripheral Neuropathy With Acupuncture, A Randomized Controlled Trial (PACT Trial)","has_exemption":false,"start_date":"2022-09-08","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05514938","publication_url":"https://clinicaltrials.gov/study/NCT05514938","title":"Polypill Strategy for Evidence-Based Management of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention in an Underserved Patient Population","has_exemption":false,"start_date":"2022-11-30","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05714553","publication_url":"https://clinicaltrials.gov/study/NCT05714553","title":"A Phase Ib/II Open Label, Multi-arm, Parallel Cohort Dose Finding and Expansion Study to Assess the Safety, Pharmacokinetics and Efficacy of NUC-3373, a Nucleotide Analogue, Given in Combination With Standard Approved Agents in Patients With Advanced Solid Tumours","has_exemption":false,"start_date":"2023-03-08","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"NuCana plc","sponsor_slug":"nucana-plc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05785715","publication_url":"https://clinicaltrials.gov/study/NCT05785715","title":"A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Phase 2 Induction Study With Long-Term Extension to Evaluate the Clinical Activity and Safety of Oral NX-13 in Participants w/ Moderate to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2023-04-24","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05427201","publication_url":"https://clinicaltrials.gov/study/NCT05427201","title":"Integrated Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy for Veterans With Chronic Pain and Depression","has_exemption":false,"start_date":"2023-05-22","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05589597","publication_url":"https://clinicaltrials.gov/study/NCT05589597","title":"A Global Multicenter Phase 1/2 Trial of EO4010, a Novel Microbial Derived Peptide Therapeutic Vaccine, in Combination With Nivolumab and/or Bevacizumab, for Treatment of Patients With Previously Treated Metastatic Colorectal Carcinoma","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Enterome","sponsor_slug":"enterome","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05937646","publication_url":"https://clinicaltrials.gov/study/NCT05937646","title":"Improving Providers' Decision-Making and Reducing Information Overload Using Information Visualization in EHRs","has_exemption":false,"start_date":"2023-07-24","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975099","publication_url":"https://clinicaltrials.gov/study/NCT05975099","title":"A Phase 1/2, Randomized, Observer-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Safety and Immunogenicity of Heptavalent mRNA-1975 (SR1-7) and Monovalent mRNA-1982 (SR1) in Parallel Against Lyme Disease in Healthy Participants 18 Through 70 Years of Age","has_exemption":false,"start_date":"2023-07-26","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05989048","publication_url":"https://clinicaltrials.gov/study/NCT05989048","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Zavegepant Intranasal (IN) for the Acute Treatment of Migraine in Asian Adults","has_exemption":false,"start_date":"2023-11-29","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05985343","publication_url":"https://clinicaltrials.gov/study/NCT05985343","title":"The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction","has_exemption":false,"start_date":"2024-01-15","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Clayton Petro","sponsor_slug":"clayton-petro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06230523","publication_url":"https://clinicaltrials.gov/study/NCT06230523","title":"A Phase 2, Parallel-Group, Double-Blind Study to Investigate Weight Management With LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight","has_exemption":false,"start_date":"2024-02-05","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06265025","publication_url":"https://clinicaltrials.gov/study/NCT06265025","title":"A Phase I/II, Open-label, Dose-escalation With Expansion Study of GM103 Via Intratumoral Injection, Alone and in Combination With Pembrolizumab in Adult Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors","has_exemption":false,"start_date":"2024-02-20","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"GeneMedicine Co., Ltd.","sponsor_slug":"genemedicine-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07056062","publication_url":"https://clinicaltrials.gov/study/NCT07056062","title":"Effect of Oral Calcium Carbonate on Uterine Contractility and Labor Outcomes: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-04-30","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Regional Medical Center","sponsor_slug":"arrowhead-regional-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06221111","publication_url":"https://clinicaltrials.gov/study/NCT06221111","title":"Rimegepant, a CGRP Antagonist, in the Treatment of Visceral Sensation and Chronic Abdominal Pain: A Pilot Study","has_exemption":false,"start_date":"2024-06-06","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05867407","publication_url":"https://clinicaltrials.gov/study/NCT05867407","title":"A Prospective Pragmatic Cluster-Randomized Care-as-Usual Controlled Study to Evaluate the Impact of an ECG-Based AI Algorithm to Detect Low Left Ventricular Ejection Fraction on Diagnosis Rates of LVEF ≤40% in the Outpatient Setting","has_exemption":false,"start_date":"2024-06-13","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Anumana, Inc.","sponsor_slug":"anumana-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06481085","publication_url":"https://clinicaltrials.gov/study/NCT06481085","title":"A Phase 2, Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of HDM1002 Tablets in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin or Diet and Exercise","has_exemption":false,"start_date":"2024-06-27","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","sponsor_slug":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06938984","publication_url":"https://clinicaltrials.gov/study/NCT06938984","title":"Human TECAR on Exercise Preconditioning and Post-exercise Recovery","has_exemption":false,"start_date":"2025-04-23","completion_date":"2025-05-30","has_results":false,"results_due":false,"sponsor_name":"University of Nove de Julho","sponsor_slug":"university-of-nove-de-julho","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01985087","publication_url":"https://clinicaltrials.gov/study/NCT01985087","title":"A Phase I/ II Study of Hypofractionated Radiotherapy With Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients Over 70 Years Old With Newly Diagnosed Glioblastoma","has_exemption":false,"start_date":"2014-09-30","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02807805","publication_url":"https://clinicaltrials.gov/study/NCT02807805","title":"A Phase II Study With a Lead-in Safety Phase of Abiraterone in Combination With PDMX1001/Niclosamide in Castration-Resistant Prostate Cancer (CRPC)","has_exemption":false,"start_date":"2016-10-31","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Mamta Parikh","sponsor_slug":"mamta-parikh","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02682147","publication_url":"https://clinicaltrials.gov/study/NCT02682147","title":"Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema","has_exemption":false,"start_date":"2017-07-10","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Eric A. Hoffman","sponsor_slug":"eric-a-hoffman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03179800","publication_url":"https://clinicaltrials.gov/study/NCT03179800","title":"CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™","has_exemption":false,"start_date":"2017-10-19","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Vascular Dynamics, Inc.","sponsor_slug":"vascular-dynamics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03490513","publication_url":"https://clinicaltrials.gov/study/NCT03490513","title":"Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism","has_exemption":false,"start_date":"2018-04-15","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03671044","publication_url":"https://clinicaltrials.gov/study/NCT03671044","title":"A Global, Multicenter, Three Arms, Open-label Randomized Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension Compared to Taxotere® (Docetaxel Injection Concentrate) in Triple-negative Breast Cancer Patients With Locally Advanced or Metastatic Breast Cancer After Failure to Prior Chemotherapy","has_exemption":false,"start_date":"2018-07-10","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Jina Pharmaceuticals Inc.","sponsor_slug":"jina-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03905031","publication_url":"https://clinicaltrials.gov/study/NCT03905031","title":"Defining The Operating Characteristics of Near-Infrared Spectroscopy (NIRS) in The Diagnosis of Pediatric Traumatic Intracranial Hemorrhage","has_exemption":false,"start_date":"2019-04-15","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Dayton Children's Hospital","sponsor_slug":"dayton-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03762759","publication_url":"https://clinicaltrials.gov/study/NCT03762759","title":"Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes","has_exemption":false,"start_date":"2019-05-10","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03814967","publication_url":"https://clinicaltrials.gov/study/NCT03814967","title":"Transcranial Direct Current Stimulation (tDCS) Studies of Behavioral and Electrophysiological (EEG) Correlates of Higher-Order Cognition","has_exemption":false,"start_date":"2019-05-22","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03992755","publication_url":"https://clinicaltrials.gov/study/NCT03992755","title":"A Global, Open-Label Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Inhaled LIQ861 (Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients","has_exemption":false,"start_date":"2019-07-18","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Liquidia Technologies, Inc.","sponsor_slug":"liquidia-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04040387","publication_url":"https://clinicaltrials.gov/study/NCT04040387","title":"TNT/NW: Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)","has_exemption":false,"start_date":"2019-07-24","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"NightWare","sponsor_slug":"nightware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04193306","publication_url":"https://clinicaltrials.gov/study/NCT04193306","title":"ACAV: Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients","has_exemption":false,"start_date":"2019-11-18","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Institute for Clinical and Experimental Medicine","sponsor_slug":"institute-for-clinical-and-experimental-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03893370","publication_url":"https://clinicaltrials.gov/study/NCT03893370","title":"A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis","has_exemption":false,"start_date":"2020-07-09","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"CSA Medical, Inc.","sponsor_slug":"csa-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04032626","publication_url":"https://clinicaltrials.gov/study/NCT04032626","title":"MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease","has_exemption":false,"start_date":"2020-07-22","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","sponsor_slug":"st-josephs-hospital-and-medical-center-phoenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04435288","publication_url":"https://clinicaltrials.gov/study/NCT04435288","title":"SPondyloArthritis: Inducing Drug-free Remission by Early TNF-Alpha bloCkade Under Guidance of Single Cell RNA Sequencing and Epigenetic Profiling. (The SPARTACUS Trial)","has_exemption":false,"start_date":"2020-08-24","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Ghent","sponsor_slug":"university-hospital-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03926520","publication_url":"https://clinicaltrials.gov/study/NCT03926520","title":"Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia","has_exemption":false,"start_date":"2021-01-28","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Brent Forester","sponsor_slug":"brent-forester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04268706","publication_url":"https://clinicaltrials.gov/study/NCT04268706","title":"A Phase 2 Multi-Center Study Evaluating the Safety and Efficacy of CD30-Directed Genetically Modified Autologous T Cells (CD30.CAR-T) in Adult and Pediatric Patients With Relapsed or Refractory Classical Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-02-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Tessa Therapeutics","sponsor_slug":"tessa-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04745234","publication_url":"https://clinicaltrials.gov/study/NCT04745234","title":"Open-Label, Phase 2 Study to Assess the Safety of Mogamulizumab Given Every 4 Weeks Following Induction in Participants With Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL)","has_exemption":false,"start_date":"2021-08-16","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Kyowa Kirin, Inc.","sponsor_slug":"kyowa-kirin-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04898504","publication_url":"https://clinicaltrials.gov/study/NCT04898504","title":"EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2","has_exemption":false,"start_date":"2021-08-23","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Oslo University Hospital","sponsor_slug":"oslo-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04847739","publication_url":"https://clinicaltrials.gov/study/NCT04847739","title":"Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)","has_exemption":false,"start_date":"2021-09-13","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Avobis Bio, LLC","sponsor_slug":"avobis-bio-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04987892","publication_url":"https://clinicaltrials.gov/study/NCT04987892","title":"Investigating Medication vs. Prostatic Urethral Lift: Assessment and Comparison of Therapies for Benign Prostatic Hyperplasia","has_exemption":false,"start_date":"2021-12-06","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"NeoTract, Inc.","sponsor_slug":"neotract-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04731844","publication_url":"https://clinicaltrials.gov/study/NCT04731844","title":"Efficacy of Curcumin and Piperine in Patients on Active Surveillance for Either Monoclonal Gammopathy of Unknown Significance (MGUS), Low-risk Smoldering Multiple Myeloma (SMM) or Early Stage Prostate Cancer: A Pilot Study","has_exemption":false,"start_date":"2021-12-14","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Rochester","sponsor_slug":"university-of-rochester","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254379","publication_url":"https://clinicaltrials.gov/study/NCT05254379","title":"Transcranial Direct Current Stimulation Treatment for Warriors Experiencing Chronic Pain (tDCS for Warriors)","has_exemption":false,"start_date":"2022-03-04","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05160532","publication_url":"https://clinicaltrials.gov/study/NCT05160532","title":"Intraarticular Dextrose Prolotherapy for Symptomatic Knee Osteoarthritis","has_exemption":false,"start_date":"2022-04-10","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05119140","publication_url":"https://clinicaltrials.gov/study/NCT05119140","title":"Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis","has_exemption":false,"start_date":"2022-06-10","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05694455","publication_url":"https://clinicaltrials.gov/study/NCT05694455","title":"Clinical Utility of Longitudinal Measurement of Hemodynamic Incoherence and Endothelial","has_exemption":false,"start_date":"2022-07-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Denver Health and Hospital Authority","sponsor_slug":"denver-health-and-hospital-authority","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04858776","publication_url":"https://clinicaltrials.gov/study/NCT04858776","title":"Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT (DEXTERITY-SCI)","has_exemption":false,"start_date":"2022-08-08","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Mercator MedSystems, Inc.","sponsor_slug":"mercator-medsystems-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05377450","publication_url":"https://clinicaltrials.gov/study/NCT05377450","title":"Prospective Randomized Study of Cementless Versus Cemented Unicompartmental Knee Arthroplasty (UKA)","has_exemption":false,"start_date":"2022-08-29","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"JIS Research Institute","sponsor_slug":"jis-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05402371","publication_url":"https://clinicaltrials.gov/study/NCT05402371","title":"A Phase 2B, Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rencofilstat in Adult Subjects With Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis","has_exemption":false,"start_date":"2022-10-15","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Hepion Pharmaceuticals, Inc.","sponsor_slug":"hepion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05764564","publication_url":"https://clinicaltrials.gov/study/NCT05764564","title":"External Body Pressure and the Impact on Exercise in Heart Failure With Preserved Ejection","has_exemption":false,"start_date":"2023-04-21","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05823844","publication_url":"https://clinicaltrials.gov/study/NCT05823844","title":"Improvement of Restorative Sleep and Post-surgical Insomnia Following Suvorexant Administration","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838651","publication_url":"https://clinicaltrials.gov/study/NCT05838651","title":"The Combination of BioHorizon's Striate+ Membrane in Conjunction With MinerOss X Plug for Providing Hard Tissue Regeneration in Socket Preservation Procedure","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Harvard School of Dental Medicine","sponsor_slug":"harvard-school-of-dental-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745999","publication_url":"https://clinicaltrials.gov/study/NCT06745999","title":"A Single Center, Observational Study to Evaluate the Effectiveness and Safety of Cryotherapy in Combination with 10% ALA Gel Red Light PDT in the Treatment of Actinic Keratosis on the Full Face.","has_exemption":false,"start_date":"2023-05-03","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Psoriasis Treatment Center of Central New Jersey","sponsor_slug":"psoriasis-treatment-center-of-central-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06587867","publication_url":"https://clinicaltrials.gov/study/NCT06587867","title":"Efficacy, Safety and Tolerability of Efgartigimod in Patients with Seronegative Generalized Myasthenia Gravis: an Open-Label Study","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University Health Network, Toronto","sponsor_slug":"university-health-network-toronto","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05584748","publication_url":"https://clinicaltrials.gov/study/NCT05584748","title":"Effects of Transcranial Direct Current Stimulation (tDCS) on Cognition in Older Adults With Mild Cognitive Impairment: A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-06-30","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Tung Wah College","sponsor_slug":"tung-wah-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05897723","publication_url":"https://clinicaltrials.gov/study/NCT05897723","title":"Safety and Efficacy of Fractional Radiofrequency for the Reduction of Surgical Scar Formation","has_exemption":false,"start_date":"2023-09-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Venus Concept","sponsor_slug":"venus-concept","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05559567","publication_url":"https://clinicaltrials.gov/study/NCT05559567","title":"Axial Length With Adult Onset Myopia","has_exemption":false,"start_date":"2023-09-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Art Optical Contact Lens, Inc.","sponsor_slug":"art-optical-contact-lens-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005428","publication_url":"https://clinicaltrials.gov/study/NCT06005428","title":"A Phase 2A, Investigator & Subject Blinded, Sponsor Unblinded, Placebo-Controlled, Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia","has_exemption":false,"start_date":"2023-11-07","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Cardurion Pharmaceuticals, Inc.","sponsor_slug":"cardurion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05934669","publication_url":"https://clinicaltrials.gov/study/NCT05934669","title":"Randomized Controlled Trial of Intranasal (IN) Midazolam vs IN Dexmedetomidine vs IN Ketamine Evaluating Length of Stay After Medication Administration and Anxiolysis During Minimal Procedures in Pediatric Population in Pediatric Emergency Department","has_exemption":false,"start_date":"2023-11-14","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05812885","publication_url":"https://clinicaltrials.gov/study/NCT05812885","title":"Transcutaneous Electrical Nerve Stimulation (TENS) and Chronic Low-Back Pain: A Randomized Crossover Trial","has_exemption":false,"start_date":"2023-11-15","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Hartford","sponsor_slug":"university-of-hartford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06918080","publication_url":"https://clinicaltrials.gov/study/NCT06918080","title":"Hepatoprotective Measures for Children at High Risk of Non Alcoholic Fatty Liver Disease","has_exemption":false,"start_date":"2023-11-19","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06282978","publication_url":"https://clinicaltrials.gov/study/NCT06282978","title":"An Open Label, Multicenter, Phase II Study of Elranatamab as Single Agent for the Treatment of Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes (GEM-RANTAB)","has_exemption":false,"start_date":"2023-11-23","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"PETHEMA Foundation","sponsor_slug":"pethema-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05875571","publication_url":"https://clinicaltrials.gov/study/NCT05875571","title":"Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement: A Randomized, Double-Blind, Placebo-Controlled Trial","has_exemption":false,"start_date":"2024-02-05","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Arkansas Children's Hospital Research Institute","sponsor_slug":"arkansas-childrens-hospital-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351358","publication_url":"https://clinicaltrials.gov/study/NCT06351358","title":"A Multi-center, Open-label Study to Evaluate the Synergistic Effects of Biostimulator and Dermal Fillers for Cheek Augmentation and Correction of Contour Deficiencies","has_exemption":false,"start_date":"2024-02-19","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06035601","publication_url":"https://clinicaltrials.gov/study/NCT06035601","title":"An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections","has_exemption":false,"start_date":"2024-03-07","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05394545","publication_url":"https://clinicaltrials.gov/study/NCT05394545","title":"A Randomized, Phase II, Open-Label Study Evaluating the Nu-V3 Cranial Nerve Stimulation Treatment Device in Patients With Chronic Pain, Anxiety, Depression, and/or Sleeplessness","has_exemption":false,"start_date":"2024-03-20","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Nu-Life Solutions","sponsor_slug":"nu-life-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06546371","publication_url":"https://clinicaltrials.gov/study/NCT06546371","title":"Spinal Cord Stimulation for Intractable Mononeuropathy: a Pilot Study","has_exemption":false,"start_date":"2024-05-13","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Erasmus Medical Center","sponsor_slug":"erasmus-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06607419","publication_url":"https://clinicaltrials.gov/study/NCT06607419","title":"Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia","has_exemption":false,"start_date":"2024-05-21","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Shanghai Jiao Tong University School of Medicine","sponsor_slug":"shanghai-jiao-tong-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06370442","publication_url":"https://clinicaltrials.gov/study/NCT06370442","title":"Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult","has_exemption":false,"start_date":"2024-06-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"State University of New York - Upstate Medical University","sponsor_slug":"state-university-of-new-york-upstate-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06253702","publication_url":"https://clinicaltrials.gov/study/NCT06253702","title":"Human Cerebral Blood Flow Regulation: Sex, Mechanism, and Stress Differences (Phase 2)","has_exemption":false,"start_date":"2024-07-24","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06986343","publication_url":"https://clinicaltrials.gov/study/NCT06986343","title":"Effect of Palatal Expansion and Up-Locker Activator on Sleep Architecture and Pharynx Dimensions in Children","has_exemption":false,"start_date":"2024-08-21","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"CES University","sponsor_slug":"ces-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06444906","publication_url":"https://clinicaltrials.gov/study/NCT06444906","title":"A Two-Part, Randomized Study of Dermacyte® Amniotic Wound Care Matrix for the Treatment of Diabetic Foot Ulcers (DFU)","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Merakris Therapeutics","sponsor_slug":"merakris-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06370598","publication_url":"https://clinicaltrials.gov/study/NCT06370598","title":"A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Technophage, SA","sponsor_slug":"technophage-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618105","publication_url":"https://clinicaltrials.gov/study/NCT06618105","title":"A Prospective, Randomized, Single-dose, Double-blind, Double-dummy, Four-period, Four-treatment Crossover Pivotal Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) (of Macleods Pharmaceuticals Ltd.) to Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) (Distributed by Teva Pharmaceuticals USA, Inc.) in Adult Patients With Stable Mild Asthma","has_exemption":false,"start_date":"2024-10-15","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Macleods Pharmaceuticals Ltd","sponsor_slug":"macleods-pharmaceuticals-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06933420","publication_url":"https://clinicaltrials.gov/study/NCT06933420","title":"Feasibility/First in Human Study of Visible Spectrum, Low Level, Microbicidal Light-based Intravaginal Therapy for Treatment of Yeast and Bacterial Vaginitis","has_exemption":false,"start_date":"2024-11-06","completion_date":"2025-05-31","has_results":false,"results_due":false,"sponsor_name":"Cern Corporation","sponsor_slug":"cern-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04092634","publication_url":"https://clinicaltrials.gov/study/NCT04092634","title":"Dual-mobility vs. Single-bearing Components in THA at \"High Risk\" for Prosthetic Dislocation","has_exemption":false,"start_date":"2017-11-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03610763","publication_url":"https://clinicaltrials.gov/study/NCT03610763","title":"Harnessing Neuroplasticity to Enhance Functional Recovery in Allogeneic Hand Transplant and Heterotopic Hand Replant Recipients","has_exemption":false,"start_date":"2018-08-15","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821623","publication_url":"https://clinicaltrials.gov/study/NCT03821623","title":"Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults","has_exemption":false,"start_date":"2019-05-10","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Douglas Seals","sponsor_slug":"douglas-seals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04094961","publication_url":"https://clinicaltrials.gov/study/NCT04094961","title":"Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed/or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2019-09-18","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Omar Nadeem, MD","sponsor_slug":"omar-nadeem-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04166487","publication_url":"https://clinicaltrials.gov/study/NCT04166487","title":"Pilot Study of Serial Plasma Genotyping to Guide the Adaptive Treatment of Advanced NSCLC Receiving First-line Pembrolizumab","has_exemption":false,"start_date":"2020-01-13","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Julia K. Rotow, MD","sponsor_slug":"julia-k-rotow-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04222751","publication_url":"https://clinicaltrials.gov/study/NCT04222751","title":"Static Muscular Stretching for Treatment of Peripheral Artery Disease","has_exemption":false,"start_date":"2020-07-29","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Florida State University","sponsor_slug":"florida-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04506567","publication_url":"https://clinicaltrials.gov/study/NCT04506567","title":"Phase I/II Dose-escalation Study of Fractionated and Multiple Dose 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer","has_exemption":false,"start_date":"2020-08-18","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04300894","publication_url":"https://clinicaltrials.gov/study/NCT04300894","title":"\"Mamma Mia\" for Perinatal Health and Wellness","has_exemption":true,"start_date":"2020-10-15","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04404595","publication_url":"https://clinicaltrials.gov/study/NCT04404595","title":"Open-label, Multicenter, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous Anti-claudin 18.2 Chimeric Antigen Receptor T-cell Therapy in Subjects With Advanced Gastric, Pancreatic, or Other Specified Digestive System Cancers","has_exemption":false,"start_date":"2020-10-23","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"CARsgen Therapeutics Co., Ltd.","sponsor_slug":"carsgen-therapeutics-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04417062","publication_url":"https://clinicaltrials.gov/study/NCT04417062","title":"Phase II Trial of Olaparib in Combination With Ceralasertib in Patients With Recurrent Osteosarcoma","has_exemption":false,"start_date":"2020-11-24","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05463367","publication_url":"https://clinicaltrials.gov/study/NCT05463367","title":"Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure","has_exemption":false,"start_date":"2021-01-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04433858","publication_url":"https://clinicaltrials.gov/study/NCT04433858","title":"An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)","has_exemption":false,"start_date":"2021-03-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Sheppard Pratt Health System","sponsor_slug":"sheppard-pratt-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04680221","publication_url":"https://clinicaltrials.gov/study/NCT04680221","title":"Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial","has_exemption":false,"start_date":"2021-03-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Missouri, Kansas City","sponsor_slug":"university-of-missouri-kansas-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03811405","publication_url":"https://clinicaltrials.gov/study/NCT03811405","title":"Physiology, Imaging and Modeling of Deep Brain Stimulation for Essential Tremor","has_exemption":false,"start_date":"2021-04-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833764","publication_url":"https://clinicaltrials.gov/study/NCT04833764","title":"Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis","has_exemption":false,"start_date":"2021-06-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Khanh Nguyen","sponsor_slug":"khanh-nguyen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05086393","publication_url":"https://clinicaltrials.gov/study/NCT05086393","title":"A Prospective, Triple-Blind, Randomized Controlled Trial Evaluating Duloxetine on Post-Operative Outcomes Following Primary Total Knee Arthroplasty in Patients With and Without Central Sensitization","has_exemption":false,"start_date":"2021-11-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Rush University Medical Center","sponsor_slug":"rush-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05165654","publication_url":"https://clinicaltrials.gov/study/NCT05165654","title":"Improving Hallucinations by Targeting the Right Superior Temporal Sulcus With Electrical Stimulation","has_exemption":false,"start_date":"2021-11-01","completion_date":"2025-06-01","has_results":true,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04769206","publication_url":"https://clinicaltrials.gov/study/NCT04769206","title":"Enhancing Parasympathetic Activity to Improve Endothelial Dysfunction, Vascular Oxidative Stress in African Americans","has_exemption":false,"start_date":"2021-12-20","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05487170","publication_url":"https://clinicaltrials.gov/study/NCT05487170","title":"A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Chaperone-mediated Protein Degrader RNK05047 in Subjects With Advanced Solid Tumors (CHAMP-1)","has_exemption":false,"start_date":"2022-07-12","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Ranok Therapeutics (Hangzhou) Co., Ltd.","sponsor_slug":"ranok-therapeutics-hangzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05458544","publication_url":"https://clinicaltrials.gov/study/NCT05458544","title":"A Phase 1 Open-label, Dose-finding Multi-center Trial of [177Lu]Ludotadipep in Metastatic Castration-resistant Prostate Cancer Patients, Followed by an Open-label, Repeat Dose, Multi-center Phase 2a Trial to Assess Safety and Efficacy","has_exemption":false,"start_date":"2022-09-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"FutureChem","sponsor_slug":"futurechem","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05530772","publication_url":"https://clinicaltrials.gov/study/NCT05530772","title":"Immediate Endoscopic Necrosectomy vs. On-demand Necroectomy in Infected Walled-off Pancreatic Necrosis","has_exemption":false,"start_date":"2022-09-12","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Tehran","sponsor_slug":"university-of-tehran","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05445466","publication_url":"https://clinicaltrials.gov/study/NCT05445466","title":"Causal Lesion Network Guided Treatment of Bipolar Mania With Transcranial Electrical Stimulation","has_exemption":false,"start_date":"2022-12-16","completion_date":"2025-06-01","has_results":true,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05732532","publication_url":"https://clinicaltrials.gov/study/NCT05732532","title":"Treatment of Headache With Occipital Nerve Blocks: Comparison Trial of Anesthetic With or Without Dexamethasone","has_exemption":false,"start_date":"2023-02-17","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05860036","publication_url":"https://clinicaltrials.gov/study/NCT05860036","title":"Safety and Efficiency of VRd-based Regimen Followed by BCMA CAR-T for New-diagnosed Transplant-ineligible Multiple Myeloma Patients: a Prospective, Single-arm, Single-center, Phase II Study.","has_exemption":false,"start_date":"2023-04-04","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","sponsor_slug":"institute-of-hematology-blood-diseases-hospital-china","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05853627","publication_url":"https://clinicaltrials.gov/study/NCT05853627","title":"Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With Propranolol: Effect on Psychophysiological Reactivity During Traumatic Imagery","has_exemption":false,"start_date":"2023-06-15","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05915351","publication_url":"https://clinicaltrials.gov/study/NCT05915351","title":"A Phase II Open-Label Study of Enfortumab Vedotin in Patients With Previously Treated Locally Advanced, Recurrent, or Metastatic Pancreatic Adenocarcinoma (EPIC)","has_exemption":false,"start_date":"2023-06-30","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05842785","publication_url":"https://clinicaltrials.gov/study/NCT05842785","title":"A Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of TSN222 in Subjects With Advanced Solid Tumors or Lymphoma","has_exemption":false,"start_date":"2023-07-26","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Tyligand Bioscience (Shanghai) Limited","sponsor_slug":"tyligand-bioscience-shanghai-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05840276","publication_url":"https://clinicaltrials.gov/study/NCT05840276","title":"Cryoneurolysis Prior to Total Knee Arthroplasty for the Management of Postoperative Pain; A Randomized, Sham-controlled, Trial","has_exemption":false,"start_date":"2023-08-30","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Esbjerg Hospital - University Hospital of Southern Denmark","sponsor_slug":"esbjerg-hospital-university-hospital-of-southern-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029049","publication_url":"https://clinicaltrials.gov/study/NCT06029049","title":"Comparison of Intubation Conditions During Rapid Sequence Induction Obtained With Modified Time Principal Induction With a Standard Intubation Dose of Rocuronium Versus Succinylcholine : A Prospective Non-inferiority Randomized and Blind Trial","has_exemption":false,"start_date":"2023-09-13","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06095804","publication_url":"https://clinicaltrials.gov/study/NCT06095804","title":"A Single Center, Pilot Study to Evaluate the Feasibility of the Percutaneous Ultrasound Jejunostomy (PUJ)","has_exemption":false,"start_date":"2023-12-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"CoapTech","sponsor_slug":"coaptech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06101264","publication_url":"https://clinicaltrials.gov/study/NCT06101264","title":"Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population","has_exemption":false,"start_date":"2024-01-01","completion_date":"2025-06-01","has_results":true,"results_due":false,"sponsor_name":"Connecticut Children's Medical Center","sponsor_slug":"connecticut-childrens-medical-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06350695","publication_url":"https://clinicaltrials.gov/study/NCT06350695","title":"The ROle of Compression StocKings in Heart Failure Patients","has_exemption":false,"start_date":"2024-01-17","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03810573","publication_url":"https://clinicaltrials.gov/study/NCT03810573","title":"A Multi-Center, Prospective, Parallel Group, Randomized, Pilot Study Evaluating Safety And Preliminary Effectiveness Of NB1 Bone Graft In Subjects With Degenerative Disc Disease Undergoing Transforaminal Lumbar Interbody Fusion","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Bone Biologics Corp","sponsor_slug":"bone-biologics-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06438081","publication_url":"https://clinicaltrials.gov/study/NCT06438081","title":"Comparison Between Propess (Dinoprostone Controlled Release Pessary) and Cook Double-balloon Catheter for Cervical Priming: a Randomized Controlled Trial","has_exemption":false,"start_date":"2024-06-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06946914","publication_url":"https://clinicaltrials.gov/study/NCT06946914","title":"Misoprostol Administration Before Elective Caesarean Section to Reduce the Risk of Respiratory Morbidity in Newborns","has_exemption":false,"start_date":"2024-06-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05695391","publication_url":"https://clinicaltrials.gov/study/NCT05695391","title":"A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures","has_exemption":false,"start_date":"2024-06-07","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Laboratoire français de Fractionnement et de Biotechnologies","sponsor_slug":"laboratoire-francais-de-fractionnement-et-de-biotechnologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233591","publication_url":"https://clinicaltrials.gov/study/NCT06233591","title":"A Multicenter, Dose-Ranging Trial Evaluating the Safety, Tolerability, and Efficacy of LP-10 in Subjects With Symptomatic Oral Lichen Planus","has_exemption":false,"start_date":"2024-07-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Lipella Pharmaceuticals, Inc.","sponsor_slug":"lipella-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07093385","publication_url":"https://clinicaltrials.gov/study/NCT07093385","title":"The Effect of Intravitreal Faricimab in Patients With Refractory Macular Edema and Refractory Age Related Macular Degeneration","has_exemption":false,"start_date":"2024-09-10","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Baghdad","sponsor_slug":"university-of-baghdad","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06631300","publication_url":"https://clinicaltrials.gov/study/NCT06631300","title":"A Randomized, Placebo-controlled Trial of Prednisone in Refractory Restless Legs Syndrome: a Pilot Study","has_exemption":false,"start_date":"2024-10-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Scripps Health","sponsor_slug":"scripps-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06434194","publication_url":"https://clinicaltrials.gov/study/NCT06434194","title":"Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)","has_exemption":false,"start_date":"2024-10-31","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Cagent Vascular LLC","sponsor_slug":"cagent-vascular-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695585","publication_url":"https://clinicaltrials.gov/study/NCT06695585","title":"Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections: a Prospective Randomized Superiority Trial","has_exemption":false,"start_date":"2024-12-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06679582","publication_url":"https://clinicaltrials.gov/study/NCT06679582","title":"A Phase 1/2, Open-label Study Evaluating the Efficacy, Safety, and Pharmacokinetics (PK) of Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With CBFA2T3::GLIS2 Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2024-12-04","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Sutro Biopharma, Inc.","sponsor_slug":"sutro-biopharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06798662","publication_url":"https://clinicaltrials.gov/study/NCT06798662","title":"Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain: a Prospective, Randomized, Controlled, Triple-blind Trial","has_exemption":false,"start_date":"2025-02-01","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Xiaguang Duan","sponsor_slug":"xiaguang-duan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07011446","publication_url":"https://clinicaltrials.gov/study/NCT07011446","title":"Usability Evaluation of the Safer Seat","has_exemption":false,"start_date":"2025-04-09","completion_date":"2025-06-01","has_results":false,"results_due":false,"sponsor_name":"Julie Faieta","sponsor_slug":"julie-faieta","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03313999","publication_url":"https://clinicaltrials.gov/study/NCT03313999","title":"Measuring Skin Elasticity in Lymphedema Patients","has_exemption":false,"start_date":"2018-02-18","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04452149","publication_url":"https://clinicaltrials.gov/study/NCT04452149","title":"Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure","has_exemption":false,"start_date":"2020-09-03","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiac Rhythm and Heart Failure","sponsor_slug":"medtronic-cardiac-rhythm-and-heart-failure","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04363697","publication_url":"https://clinicaltrials.gov/study/NCT04363697","title":"A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients Who Have Been Stabilized During Hospitalization for Acute Heart Failure DAPAgliflozin and Effect on Cardiovascular Events in ACuTe Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)","has_exemption":false,"start_date":"2020-09-24","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"The TIMI Study Group","sponsor_slug":"the-timi-study-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05070351","publication_url":"https://clinicaltrials.gov/study/NCT05070351","title":"A Randomized Open-label Trial of Deprescribing Proton Pump Inhibitors to Reduce the Risk of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Creation","has_exemption":false,"start_date":"2022-01-03","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05353166","publication_url":"https://clinicaltrials.gov/study/NCT05353166","title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of REGN5381, an NPR1 Agonist, in Heart Failure Patients With Elevated Pulmonary Capillary Wedge Pressure","has_exemption":false,"start_date":"2022-06-30","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06112834","publication_url":"https://clinicaltrials.gov/study/NCT06112834","title":"Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG® in Volunteers With Existing Botulinum Immunity","has_exemption":false,"start_date":"2024-07-09","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"California Department of Public Health","sponsor_slug":"california-department-of-public-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06697223","publication_url":"https://clinicaltrials.gov/study/NCT06697223","title":"A Randomized, Multi-center, Controlled, In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous Apheresis Platelet Components Suspended in 100% Plasma Treated With the INTERCEPT Blood System for Platelets With LED Illuminator Stored for 5 Days","has_exemption":false,"start_date":"2025-01-23","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Cerus Corporation","sponsor_slug":"cerus-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07097454","publication_url":"https://clinicaltrials.gov/study/NCT07097454","title":"Effectiveness of Hypotension Prediction Index (HPI) in Preventing Hypotension in the Post-Anesthesia Care Unit (PACU): A Prospective, Randomized, Controlled Trial","has_exemption":false,"start_date":"2025-05-06","completion_date":"2025-06-02","has_results":false,"results_due":false,"sponsor_name":"Wonkwang University Hospital","sponsor_slug":"wonkwang-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01703949","publication_url":"https://clinicaltrials.gov/study/NCT01703949","title":"A Pilot Study of Weekly Brentuximab Vedotin or Brentuximab Vedotin Plus Nivolumab Every 3 Weeks in Patients With CD30+ Malignancies Refractory to Every ≥ 3 Week Brentuximab Vedotin","has_exemption":false,"start_date":"2013-03-20","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01984138","publication_url":"https://clinicaltrials.gov/study/NCT01984138","title":"REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy","has_exemption":false,"start_date":"2013-09-30","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Polly A. Niravath, MD","sponsor_slug":"polly-a-niravath-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05346380","publication_url":"https://clinicaltrials.gov/study/NCT05346380","title":"Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery","has_exemption":false,"start_date":"2020-10-29","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04340258","publication_url":"https://clinicaltrials.gov/study/NCT04340258","title":"Phase 1b/II Trial Combining PD1 Inhibition (Pembrolizumab) and Cesium 131 Brachytherapy With Salvage Surgery to Enhance Immunogenicity and Improve Local Control in Head and Neck Cancer","has_exemption":false,"start_date":"2021-02-04","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04486118","publication_url":"https://clinicaltrials.gov/study/NCT04486118","title":"A Novel Phase 2 Double-blind, Randomized, Controlled Clinical Trial to Evaluate the Efficacy of Centrally Acting, Non-toxic ACE Inhibition in Cognitive Impairment Associated With SLE","has_exemption":false,"start_date":"2021-10-01","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564715","publication_url":"https://clinicaltrials.gov/study/NCT05564715","title":"Cognitive Outcomes of Brain Stimulation As a Later-in-Life Treatment","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06149793","publication_url":"https://clinicaltrials.gov/study/NCT06149793","title":"Empagliflozin in CFRD: Efficacy and Safety of SGLT2 Inhibitor Therapy in Overweight and Obese Subjects With Cystic Fibrosis-related Diabetes: a Pilot Study","has_exemption":false,"start_date":"2024-01-08","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05546359","publication_url":"https://clinicaltrials.gov/study/NCT05546359","title":"Randomized, Double-blind, Phase 2/3 Study of IV Amisulpride as Prevention of Post-operative Nausea and Vomiting in Pediatric Patients","has_exemption":false,"start_date":"2024-01-18","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Acacia Pharma Ltd","sponsor_slug":"acacia-pharma-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06283108","publication_url":"https://clinicaltrials.gov/study/NCT06283108","title":"The Impact of Distraction During Transition to the Operating Room and Anesthesia Induction Using a Novel Virtual Reality Software Program on Pediatric Perioperative Anxiolysis and Induction Compliance.","has_exemption":false,"start_date":"2024-04-19","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Colorado","sponsor_slug":"childrens-hospital-colorado","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06203717","publication_url":"https://clinicaltrials.gov/study/NCT06203717","title":"Cranial Electrotherapy Stimulation: Piloting a Road to PTSD Prevention in First Responders","has_exemption":false,"start_date":"2024-04-29","completion_date":"2025-06-03","has_results":true,"results_due":false,"sponsor_name":"Butler Hospital","sponsor_slug":"butler-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06470828","publication_url":"https://clinicaltrials.gov/study/NCT06470828","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)","has_exemption":false,"start_date":"2024-07-02","completion_date":"2025-06-03","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03442556","publication_url":"https://clinicaltrials.gov/study/NCT03442556","title":"PLATI-PARP: A Phase 2 Study of Induction Docetaxel and Carboplatin Followed by Maintenance Rucaparib in Treatment of Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency","has_exemption":false,"start_date":"2018-08-24","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04314531","publication_url":"https://clinicaltrials.gov/study/NCT04314531","title":"A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)","has_exemption":false,"start_date":"2020-07-01","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05562063","publication_url":"https://clinicaltrials.gov/study/NCT05562063","title":"SOTA-P-CARDIA Trial: A Randomized Trial of Sotagliflozin in HFpEF Patients Without Diabetes","has_exemption":false,"start_date":"2022-10-26","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Juan Badimon","sponsor_slug":"juan-badimon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05694260","publication_url":"https://clinicaltrials.gov/study/NCT05694260","title":"An Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Bempedoic Acid in Pediatric Patients (6 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia","has_exemption":false,"start_date":"2023-01-12","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Esperion Therapeutics, Inc.","sponsor_slug":"esperion-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04789096","publication_url":"https://clinicaltrials.gov/study/NCT04789096","title":"A Phase II, Two-arm, Non-comparative, Multicentre Study of Tucatinib (ONT-380), Pembrolizumab and Trastuzumab in Patients With Pre-treated Advanced HER2-positive Breast Cancer","has_exemption":false,"start_date":"2023-03-07","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Breast Cancer Trials, Australia and New Zealand","sponsor_slug":"breast-cancer-trials-australia-and-new-zealand","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05774184","publication_url":"https://clinicaltrials.gov/study/NCT05774184","title":"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults With Active Eosinophilic Esophagitis (The \"EvolvE\" Study)","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06316999","publication_url":"https://clinicaltrials.gov/study/NCT06316999","title":"Utility of Intestinal Ultrasound as a Diagnostic Tool for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis: A Prospective Pilot Study","has_exemption":false,"start_date":"2024-07-01","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06505031","publication_url":"https://clinicaltrials.gov/study/NCT06505031","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)","has_exemption":false,"start_date":"2024-10-08","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06644924","publication_url":"https://clinicaltrials.gov/study/NCT06644924","title":"A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect and Safety of PT007 to Placebo MDI and Open-Label Ventolin® Evohaler in Adult Participants With Asthma","has_exemption":false,"start_date":"2025-02-10","completion_date":"2025-06-04","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04166058","publication_url":"https://clinicaltrials.gov/study/NCT04166058","title":"A Phase 3, Open-label, Long-term Safety Study of Oral Linaclotide Administered to Pediatric Participants With Functional Constipation (FC) or Irritable Bowel Syndrome With Constipation (IBS-C)","has_exemption":false,"start_date":"2019-11-19","completion_date":"2025-06-05","has_results":true,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03477604","publication_url":"https://clinicaltrials.gov/study/NCT03477604","title":"A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee (STAND)","has_exemption":false,"start_date":"2020-03-31","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Micro Medical Solution, Inc.","sponsor_slug":"micro-medical-solution-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262856","publication_url":"https://clinicaltrials.gov/study/NCT04262856","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination With AB122, and AB154 in Combination With AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2020-05-28","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04655976","publication_url":"https://clinicaltrials.gov/study/NCT04655976","title":"A Randomized, Open Label Phase 2/3 Study Comparing Cobolimab + Dostarlimab + Docetaxel To Dostarlimab + Docetaxel To Docetaxel Alone In Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed On Prior Anti-PD-(L)1 Therapy And Chemotherapy (COSTAR Lung)","has_exemption":false,"start_date":"2020-12-08","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04338776","publication_url":"https://clinicaltrials.gov/study/NCT04338776","title":"C.L.E.A.R. - Comparing UroLift Experience Against Rezūm","has_exemption":false,"start_date":"2021-01-22","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"NeoTract, Inc.","sponsor_slug":"neotract-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03412045","publication_url":"https://clinicaltrials.gov/study/NCT03412045","title":"Hyperbaric Oxygen Therapy in Sickle Cell Pain","has_exemption":false,"start_date":"2022-09-01","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05879718","publication_url":"https://clinicaltrials.gov/study/NCT05879718","title":"A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE CLINICAL EFFECT, PHARMACODYNAMIC, PHARMACOKINETIC AND SAFETY PROFILE OF PF 06823859 IN ADULT PARTICIPANTS WITH ACTIVE CLE OR SLE WITH CUTANEOUS MANIFESTATIONS","has_exemption":false,"start_date":"2023-07-07","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06010004","publication_url":"https://clinicaltrials.gov/study/NCT06010004","title":"A Phase 3, Long-term Safety Study of LY3502970 in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone or in Combination With Oral Antihyperglycemic Medications (ACHIEVE-J)","has_exemption":false,"start_date":"2023-09-28","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06062433","publication_url":"https://clinicaltrials.gov/study/NCT06062433","title":"Assessment of Feasibility and Effectiveness of Remote Asthma Management Via an Integrated Artificial Intelligence-assisted Clinical Decision Support System With Mobile Device Compared With Usual Asthma Care in Pediatric Participants With Asthma Aged 6-17 Years: A Parallel Group, Non-blinded, Dual-site, 2-arm, Pragmatic Randomized Clinical Trial","has_exemption":false,"start_date":"2023-12-05","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06293365","publication_url":"https://clinicaltrials.gov/study/NCT06293365","title":"A Randomized, Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL Pre-filled Syringe With 1 mL Pre-filled Syringe in Adult Participants With Autoimmune Disease","has_exemption":false,"start_date":"2024-07-02","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06246552","publication_url":"https://clinicaltrials.gov/study/NCT06246552","title":"Multicenter, Randomized, Double-blind, Placebo-controlled, Single-dose Phase 2 Study of the Safety and Efficacy of JTM201 (Botulinum Toxin Type A) to Treat Moderate or Severe Glabellar Lines","has_exemption":false,"start_date":"2024-10-26","completion_date":"2025-06-05","has_results":false,"results_due":false,"sponsor_name":"Jetema USA Inc.","sponsor_slug":"jetema-usa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03924895","publication_url":"https://clinicaltrials.gov/study/NCT03924895","title":"A Randomized Phase 3 Study Evaluating Cystectomy With Perioperative Pembrolizumab and Cystectomy With Perioperative Enfortumab Vedotin and Pembrolizumab Versus Cystectomy Alone in Participants Who Are Cisplatin-Ineligible or Decline Cisplatin With Muscle-Invasive Bladder Cancer (KEYNOTE-905/EV-303)","has_exemption":false,"start_date":"2019-07-24","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04195945","publication_url":"https://clinicaltrials.gov/study/NCT04195945","title":"Randomized Phase 2 Trial of CPX-351 (Vyxeos) vs. CLAG-M (Cladribine, Cytarabine, G-CSF, and Mitoxantrone) in Medically Less-Fit Adults With Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm","has_exemption":false,"start_date":"2020-03-11","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04817241","publication_url":"https://clinicaltrials.gov/study/NCT04817241","title":"Clinical Evaluation of ASTX727 in Combination With Venetoclax All-Oral Therapy vs Standard of Care Cytarabine and Anthracycline Induction Chemotherapy for Younger FLT3WT Patients With ELN High- Risk Acute Myeloid Leukemia","has_exemption":false,"start_date":"2022-02-10","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05144789","publication_url":"https://clinicaltrials.gov/study/NCT05144789","title":"Personalized Therapeutic Neuromodulation for Anhedonic Depression","has_exemption":false,"start_date":"2022-05-31","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588284","publication_url":"https://clinicaltrials.gov/study/NCT05588284","title":"Effect of Endovascular Thrombectomy for Femoral Popliteal Vein Thrombosis on Venous Valve Function Maintenance: a Single-center, Single-arm Prospective Observational Study","has_exemption":false,"start_date":"2022-06-06","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","sponsor_slug":"shanghai-ninth-peoples-hospital-affiliated-to-shanghai-jiao-tong-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05537402","publication_url":"https://clinicaltrials.gov/study/NCT05537402","title":"Phase II Multi-center Randomized, Open-label, Trial of Atezolizumab and Bevacizumab vs Locoregional Therapy (Transarterial Chemoembozliation or Radioembolization) as First-line Therapy in Patients With Large Intermediate-stage Hepatocellular Carcinoma","has_exemption":false,"start_date":"2023-09-27","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06238687","publication_url":"https://clinicaltrials.gov/study/NCT06238687","title":"A Phase I/IIa Study to Evaluate the Safety, Tolerability , Pharmacokinetics and Preliminary Efficacy of STRO-002 in Chinese Adults With Advanced Epithelial Ovarian Cancer, Endometrial Cancer, and Other Advanced Malignant Solid Tumors.","has_exemption":false,"start_date":"2023-11-08","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Tasly Pharmaceutical Group Co., Ltd","sponsor_slug":"tasly-pharmaceutical-group-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06340958","publication_url":"https://clinicaltrials.gov/study/NCT06340958","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Design, Phase 2 Study to Assess the Efficacy and Safety of CLE-100 as an Adjunctive Treatment for Major Depressive Disorder Patients With Inadequate Response to Standard Antidepressants","has_exemption":false,"start_date":"2024-03-18","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Clexio Biosciences Ltd.","sponsor_slug":"clexio-biosciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05949632","publication_url":"https://clinicaltrials.gov/study/NCT05949632","title":"A Phase 1/2 Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-04-16","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06916845","publication_url":"https://clinicaltrials.gov/study/NCT06916845","title":"Data Collection for CapsoView AI Software Development for the CapsoCam® Colon (CV-3E)","has_exemption":false,"start_date":"2025-03-16","completion_date":"2025-06-06","has_results":false,"results_due":false,"sponsor_name":"Capso Vision, Inc.","sponsor_slug":"capso-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06614933","publication_url":"https://clinicaltrials.gov/study/NCT06614933","title":"How Does the Type of Waveform Affect Tolerability With Transcutaneous Auricular Vagus Nerve Stimulation?","has_exemption":false,"start_date":"2024-12-15","completion_date":"2025-06-07","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03195777","publication_url":"https://clinicaltrials.gov/study/NCT03195777","title":"Novel PET/CT and Treatment Strategies to Reduce PTS Following DVT","has_exemption":false,"start_date":"2017-12-20","completion_date":"2025-06-08","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04064827","publication_url":"https://clinicaltrials.gov/study/NCT04064827","title":"A Phase 3, Prospective, Open-Label, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Paricalcitol Oral Solution for the Treatment of Secondary Hyperparathyroidism in Pediatric Subjects Ages 0 to 9 Years With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis","has_exemption":false,"start_date":"2020-09-16","completion_date":"2025-06-09","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03399773","publication_url":"https://clinicaltrials.gov/study/NCT03399773","title":"Pilot Study: Infusion of Off-the-Shelf Ex Vivo Expanded Cryopreserved Progenitor Cells (Dilanubicel) in the Setting of Single Cord Blood Transplantation for Patients With Hematologic Malignancies","has_exemption":false,"start_date":"2022-05-10","completion_date":"2025-06-09","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05123703","publication_url":"https://clinicaltrials.gov/study/NCT05123703","title":"A Phase III Multicenter, Randomized, Double-blind, Double-dummy Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis","has_exemption":false,"start_date":"2022-05-19","completion_date":"2025-06-09","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05333549","publication_url":"https://clinicaltrials.gov/study/NCT05333549","title":"Istradefylline for Parkinson Disease Cognitive Impairment","has_exemption":false,"start_date":"2022-07-18","completion_date":"2025-06-09","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05760313","publication_url":"https://clinicaltrials.gov/study/NCT05760313","title":"A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age With Functional Constipation (FC).","has_exemption":false,"start_date":"2023-04-27","completion_date":"2025-06-09","has_results":true,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":false,"days_late":null}]}